This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


3kck

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 23: Line 23:
==About this Structure==
==About this Structure==
-
3KCK is a 1 chain structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3KCK OCA].
+
3KCK is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3KCK OCA].
==Reference==
==Reference==
Line 48: Line 48:
[[Category: Tyrosine-protein kinase]]
[[Category: Tyrosine-protein kinase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Dec 16 11:52:24 2009''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Feb 17 09:58:31 2010''

Revision as of 07:58, 17 February 2010

Template:STRUCTURE 3kck

Contents

A Novel Chemotype of Kinase Inhibitors

Template:ABSTRACT PUBMED 19945871

Disease

Known disease associated with this structure: Leukemia, acute myelogenous OMIM:[147796], Myelofibrosis, idiopathic OMIM:[147796], Myeloproliferative disorder with erythrocytosis OMIM:[147796], Polycythemia vera OMIM:[147796], Thrombocythemia, essential OMIM:[147796], Budd-Chiari syndrome OMIM:[147796]

About this Structure

3KCK is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

  • Wang T, Ledeboer MW, Duffy JP, Salituro FG, Pierce AC, Zuccola HJ, Block E, Shlyakter D, Hogan JK, Bennani YL. A novel chemotype of kinase inhibitors: Discovery of 3,4-ring fused 7-azaindoles and deazapurines as potent JAK2 inhibitors. Bioorg Med Chem Lett. 2010 Jan 1;20(1):153-6. Epub 2009 Nov 12. PMID:19945871 doi:10.1016/j.bmcl.2009.11.021

Page seeded by OCA on Wed Feb 17 09:58:31 2010

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools